Publicacións en colaboración con investigadores/as de Hospital Universitario La Paz (14)

2024

  1. Impact of comorbidities on the achievement of specific therapeutic goals in biologic-treated asthma patients

    Allergy: European Journal of Allergy and Clinical Immunology

2023

  1. Factors associated with suboptimal response to monoclonal antibodies in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology

  2. Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response

    Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 1, pp. 1-13

  3. Validation of the Asthma Impairment and Risk Questionnaire in Spain: A Useful Tool for Assessing Asthma Control in Adolescents and Adults

    Journal of Investigational Allergology and Clinical Immunology

2021

  1. Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 7, pp. 2725-2731

  2. EAACI Biologicals Guidelines—Recommendations for severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44

2020

  1. Characteristics and treatment regimens across ERS SHARP severe asthma registries

    European Respiratory Journal, Vol. 55, Núm. 1

  2. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057

  3. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042

  4. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068

2018

  1. The Role of FENO in the Diagnosis and Control of Asthma. Expert Multidisciplinary Group Debate during the Asthma Meeting Point 2017

    Archivos de Bronconeumologia

2017

  1. Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA)

    Archivos de Bronconeumologia, Vol. 53, Núm. 8, pp. 443-449

2016

  1. GEMA 4.0 Spanish guidelines of the management of Asthma

    Journal of Investigational Allergology and Clinical Immunology

2012

  1. Involvement of Spanish Pulmonology Centers in Patient Care, Postgraduate Education and Research in Asthma: The Results of the ATENEA Survey

    Archivos de Bronconeumologia, Vol. 48, Núm. 4, pp. 114-119